The glycosylation of NF-κB, Nrf2, and TGF-β is blamed for the worsened DN outcome, while the phosphorylation and acetylation of these key molecules have a different effect on DN patients (see Figure 3). The gene discussed is NFE2L2; the disease is liver dysplastic nodule.